Skip to main content
. 2014 Jun;52(6):1938–1946. doi: 10.1128/JCM.03238-13

TABLE 3.

Differences in cytokine and chemokine levels between TD and JSF patients

Disease phase and cytokine or chemokinea Avg level ± SD (pg/ml) in patients with:
P valueb
TD (n = 32) JSF (n = 21)
Acute
    TNF-α 13.8 ± 13.5 35.0 ± 27.5 <0.001
    IL-6 11.6 ± 17.2 65.8 ± 73.4 <0.01
    IFN-γ 73.4 ± 78.1 220.3 ± 228.0 <0.001
    IL-8 13.2 ± 10.5 46.3 ± 35.3 <0.001
    IP-10 3,215.9 ± 2,786.1 12,298.3 ± 9,539.4 <0.001
    MCP-1 467.5 ± 492.0 1,365.8 ± 816.7 <0.001
    MIP-1α 15.0 ± 25.3 53.9 ± 41.0 <0.001
    MIP-1β 88.5 ± 63.5 127.7 ± 54.0 <0.05
    Eotaxin 67.1 ± 31.7 68.2 ± 40.1 NS
Convalescent
    TNF-α 4.1 ± 4.4 6.8 ± 6.9 <0.05
    IL-6 0 ± 0 2.2 ± 7.0 NS
    IFN-γ 3.5 ± 3.7 16.7 ± 7.5 NS
    IL-8 6.1 ± 7.5 18.5 ± 23.3 <0.01
    IP-10 550.8 ± 534.2 730.9 ± 805.2 NS
    MCP-1 253.9 ± 229.1 553.3 ± 153.3 <0.001
    MIP-1α 7.3 ± 13.9 9.5 ± 16.9 NS
    MIP-1β 63.7 ± 46.2 65.7 ± 29.6 NS
    Eotaxin 77.7 ± 31.8 65.3 ± 40.4 NS
a

Normal levels: TNF-α, <2.3 pg/ml; IL-6, <3.0 pg/ml; IFN-γ, <7.3 pg/ml; IL-8, <3.0 pg/ml; IP-10, MCP-1, MIP-1α and MIP-1β, normal levels not determined.

b

P values were determined by t test. NS, not significant.